The median levels of MACC1 in CRC patients were notably increased than normal controls (16.91 ng/mL vs 1.51 ng/mL; P < 0.001), which could effectively distinguish the CRC patients from normal controls with the ROC curve (AUC = 0.960; P < 0.001). This evidence concerns the gene MACC1 and colorectal carcinoma.